Bank of America’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Sell |
421,726
-50,235
| -11% | -$804K | ﹤0.01% | 3058 |
|
|
2025
Q1 | $8.07M | Buy |
471,961
+130,426
| +38% | +$2.23M | ﹤0.01% | 2850 |
|
|
2024
Q4 | $8.46M | Buy |
341,535
+114,511
| +50% | +$2.84M | ﹤0.01% | 2642 |
|
|
2024
Q3 | $6.47M | Sell |
227,024
-16,310
| -7% | -$465K | ﹤0.01% | 2978 |
|
|
2024
Q2 | $6.42M | Buy |
243,334
+34,704
| +17% | +$916K | ﹤0.01% | 2907 |
|
|
2024
Q1 | $6.74M | Sell |
208,630
-13,746
| -6% | -$444K | ﹤0.01% | 2852 |
|
|
2023
Q4 | $9.37M | Sell |
222,376
-380,416
| -63% | -$16M | ﹤0.01% | 2474 |
|
|
2023
Q3 | $23.1M | Buy |
602,792
+425,932
| +241% | +$16.4M | ﹤0.01% | 1628 |
|
|
2023
Q2 | $3.36M | Sell |
176,860
-232,954
| -57% | -$4.42M | ﹤0.01% | 3170 |
|
|
2023
Q1 | $6.36M | Buy |
409,814
+175,011
| +75% | +$2.71M | ﹤0.01% | 2811 |
|
|
2022
Q4 | $4.17M | Buy |
234,803
+209,331
| +822% | +$3.72M | ﹤0.01% | 3047 |
|
|
2022
Q3 | $142K | Buy |
25,472
+11,048
| +77% | +$61.6K | ﹤0.01% | 5361 |
|
|
2022
Q2 | $56K | Sell |
14,424
-11,743
| -45% | -$45.6K | ﹤0.01% | 5983 |
|
|
2022
Q1 | $144K | Sell |
26,167
-199,281
| -88% | -$1.1M | ﹤0.01% | 5889 |
|
|
2021
Q4 | $1.92M | Buy |
225,448
+130,142
| +137% | +$1.11M | ﹤0.01% | 3945 |
|
|
2021
Q3 | $828K | Sell |
95,306
-39,415
| -29% | -$342K | ﹤0.01% | 4495 |
|
|
2021
Q2 | $1.43M | Buy |
134,721
+10,428
| +8% | +$110K | ﹤0.01% | 3986 |
|
|
2021
Q1 | $1.99M | Buy |
124,293
+97,425
| +363% | +$1.56M | ﹤0.01% | 3746 |
|
|
2020
Q4 | $1.24M | Sell |
26,868
-6,582
| -20% | -$304K | ﹤0.01% | 3716 |
|
|
2020
Q3 | $1.18M | Buy |
33,450
+21,453
| +179% | +$756K | ﹤0.01% | 3593 |
|
|
2020
Q2 | $292K | Buy |
11,997
+3,585
| +43% | +$87.3K | ﹤0.01% | 4467 |
|
|
2020
Q1 | $131K | Buy |
+8,412
| New | +$131K | ﹤0.01% | 4787 |
|